Click here to get full coverage on BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis - Yahoo Finance

BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis  Yahoo Finance

BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis - Yahoo Finance

Click here to get full coverage on Apogee Therapeutics Inc. $APGE Shares Sold by Siren L.L.C. - MarketBeat

Apogee Therapeutics Inc. $APGE Shares Sold by Siren L.L.C.  MarketBeat

Apogee Therapeutics Inc. $APGE Shares Sold by Siren L.L.C. - MarketBeat

Click here to get full coverage on Apogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025 - simplywall.st

Apogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025  simplywall.st

Apogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025 - simplywall.st

Click here to get full coverage on First 3-6 Month Dosing Biologic: Apogee's APG777 Shows Best-in-Class Potential for Atopic Dermatitis - Stock Titan

First 3-6 Month Dosing Biologic: Apogee's APG777 Shows Best-in-Class Potential for Atopic Dermatitis  Stock Titan

First 3-6 Month Dosing Biologic: Apogee's APG777 Shows Best-in-Class Potential for Atopic Dermatitis - Stock Titan

Click here to get full coverage on New Analyst Forecast: $APGE Given $87.0 Price Target - Quiver Quantitative

New Analyst Forecast: $APGE Given $87.0 Price Target  Quiver Quantitative

New Analyst Forecast: $APGE Given $87.0 Price Target - Quiver Quantitative

Click here to get full coverage on Buyback Watch: What are APGE’s recent SEC filings showing - Entry Point & Low Drawdown Momentum Trade Ideas - خودرو بانک

Buyback Watch: What are APGE’s recent SEC filings showing - Entry Point & Low Drawdown Momentum Trade Ideas  خودرو بانک

Buyback Watch: What are APGE’s recent SEC filings showing - Entry Point & Low Drawdown Momentum Trade Ideas - خودرو بانک

Click here to get full coverage on Apogee Therapeutics Inc. $APGE Shares Purchased by Woodline Partners LP - MarketBeat

Apogee Therapeutics Inc. $APGE Shares Purchased by Woodline Partners LP  MarketBeat

Apogee Therapeutics Inc. $APGE Shares Purchased by Woodline Partners LP - MarketBeat

Click here to get full coverage on Did Positive APG777 Data and Leadership Stock Sale Just Shift Apogee Therapeutics' (APGE) Investment Narrative? - simplywall.st

Did Positive APG777 Data and Leadership Stock Sale Just Shift Apogee Therapeutics' (APGE) Investment Narrative?  simplywall.st

Did Positive APG777 Data and Leadership Stock Sale Just Shift Apogee Therapeutics' (APGE) Investment Narrative? - simplywall.st

Click here to get full coverage on Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High? - Yahoo Finance

Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High?  Yahoo Finance

Wall Street Analysts See a 152.41% Upside in Apogee Therapeutics Inc. (APGE): Can the Stock Really Move This High? - Yahoo Finance

Click here to get full coverage on Biotech Innovator Apogee Therapeutics Featured at Upcoming Stifel 2025 Immunology Conference - Stock Titan

Biotech Innovator Apogee Therapeutics Featured at Upcoming Stifel 2025 Immunology Conference  Stock Titan

Biotech Innovator Apogee Therapeutics Featured at Upcoming Stifel 2025 Immunology Conference - Stock Titan

Click here to get full coverage on Geopolitics Watch: What’s the beta of APGE stock - Weekly Trading Summary & Weekly Market Pulse Alerts - خودرو بانک

Geopolitics Watch: What’s the beta of APGE stock - Weekly Trading Summary & Weekly Market Pulse Alerts  خودرو بانک

Geopolitics Watch: What’s the beta of APGE stock - Weekly Trading Summary & Weekly Market Pulse Alerts - خودرو بانک

Click here to get full coverage on Alliancebernstein L.P. Decreases Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat

Alliancebernstein L.P. Decreases Holdings in Apogee Therapeutics Inc. $APGE  MarketBeat

Alliancebernstein L.P. Decreases Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat

Click here to get full coverage on Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - Yahoo Finance

Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors  Yahoo Finance

Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - Yahoo Finance

Click here to get full coverage on Earnings Miss: What are the analyst revisions for BODIIs APGE stock a good investment in YEAR - Market Activity Summary & Low Drawdown Investment Strategies - خودرو بانک

Earnings Miss: What are the analyst revisions for BODIIs APGE stock a good investment in YEAR - Market Activity Summary & Low Drawdown Investment Strategies  خودرو بانک

Earnings Miss: What are the analyst revisions for BODIIs APGE stock a good investment in YEAR - Market Activity Summary & Low Drawdown Investment Strategies - خودرو بانک

Click here to get full coverage on Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - Yahoo Finance

Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug  Yahoo Finance

Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - Yahoo Finance

Click here to get full coverage on Parkman Healthcare Partners LLC Reduces Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat

Parkman Healthcare Partners LLC Reduces Holdings in Apogee Therapeutics Inc. $APGE  MarketBeat

Parkman Healthcare Partners LLC Reduces Holdings in Apogee Therapeutics Inc. $APGE - MarketBeat

Click here to get full coverage on BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - Yahoo Finance

BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating  Yahoo Finance

BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - Yahoo Finance

Click here to get full coverage on Birchview Capital LP Makes New Investment in Apogee Therapeutics Inc. $APGE - MarketBeat

Birchview Capital LP Makes New Investment in Apogee Therapeutics Inc. $APGE  MarketBeat

Birchview Capital LP Makes New Investment in Apogee Therapeutics Inc. $APGE - MarketBeat

Click here to get full coverage on Apogee Therapeutics Inc. $APGE Shares Acquired by Allostery Investments LP - MarketBeat

Apogee Therapeutics Inc. $APGE Shares Acquired by Allostery Investments LP  MarketBeat

Apogee Therapeutics Inc. $APGE Shares Acquired by Allostery Investments LP - MarketBeat

Click here to get full coverage on Granahan Investment Management LLC Buys 15,486 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat

Granahan Investment Management LLC Buys 15,486 Shares of Apogee Therapeutics Inc. $APGE  MarketBeat

Granahan Investment Management LLC Buys 15,486 Shares of Apogee Therapeutics Inc. $APGE - MarketBeat

Click here to get full coverage on Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE) - Yahoo Finance

Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE)  Yahoo Finance

Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE) - Yahoo Finance

Click here to get full coverage on Rafferty Asset Management LLC Decreases Stock Position in Apogee Therapeutics Inc. $APGE - MarketBeat

Rafferty Asset Management LLC Decreases Stock Position in Apogee Therapeutics Inc. $APGE  MarketBeat

Rafferty Asset Management LLC Decreases Stock Position in Apogee Therapeutics Inc. $APGE - MarketBeat

Click here to get full coverage on Apogee's APG777 Achieves 71% Efficacy in Phase 2 Atopic Dermatitis Trial | APGE Stock News - Stock Titan

Apogee's APG777 Achieves 71% Efficacy in Phase 2 Atopic Dermatitis Trial | APGE Stock News  Stock Titan

Apogee's APG777 Achieves 71% Efficacy in Phase 2 Atopic Dermatitis Trial | APGE Stock News - Stock Titan

Click here to get full coverage on Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis (APGE) - Seeking Alpha

Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis (APGE)  Seeking Alpha

Apogee Therapeutics: Funding Supports Best-In-Class Ambitions In Atopic Dermatitis (APGE) - Seeking Alpha

Click here to get full coverage on Aug Mood: Does APGE have a sustainable dividend - 2025 Market Sentiment & Risk Managed Investment Signals - خودرو بانک

Aug Mood: Does APGE have a sustainable dividend - 2025 Market Sentiment & Risk Managed Investment Signals  خودرو بانک

Aug Mood: Does APGE have a sustainable dividend - 2025 Market Sentiment & Risk Managed Investment Signals - خودرو بانک

Click here to get full coverage on Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results - Yahoo Finance

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results  Yahoo Finance

Apogee Therapeutics Provides Pipeline Progress and Reports Second Quarter 2025 Financial Results - Yahoo Finance

Click here to get full coverage on Apogee falls after results from atopic dermatitis trial (APGE:NASDAQ) - Seeking Alpha

Apogee falls after results from atopic dermatitis trial (APGE:NASDAQ)  Seeking Alpha

Apogee falls after results from atopic dermatitis trial (APGE:NASDAQ) - Seeking Alpha

Click here to get full coverage on Breakthrough: Apogee's New Atopic Dermatitis Drug Achieves 71% Efficacy with 6-Month Dosing Potential - Stock Titan

Breakthrough: Apogee's New Atopic Dermatitis Drug Achieves 71% Efficacy with 6-Month Dosing Potential  Stock Titan

Breakthrough: Apogee's New Atopic Dermatitis Drug Achieves 71% Efficacy with 6-Month Dosing Potential - Stock Titan

Click here to get full coverage on Noteworthy Monday Option Activity: IBM, APGE, AFRM - Nasdaq

Noteworthy Monday Option Activity: IBM, APGE, AFRM  Nasdaq

Noteworthy Monday Option Activity: IBM, APGE, AFRM - Nasdaq

Click here to get full coverage on Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans  simplywall.st

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans - simplywall.st

Click here to get full coverage on Notable Thursday Option Activity: ABBV, U, APGE - Nasdaq

Notable Thursday Option Activity: ABBV, U, APGE  Nasdaq

Notable Thursday Option Activity: ABBV, U, APGE - Nasdaq

Click here to get full coverage on Key Phase 2 Data Drop Tomorrow: Apogee's New Atopic Dermatitis Drug Faces Critical Test - Stock Titan

Key Phase 2 Data Drop Tomorrow: Apogee's New Atopic Dermatitis Drug Faces Critical Test  Stock Titan

Key Phase 2 Data Drop Tomorrow: Apogee's New Atopic Dermatitis Drug Faces Critical Test - Stock Titan

Click here to get full coverage on APGE Makes Bullish Cross Above Critical Moving Average - Nasdaq

APGE Makes Bullish Cross Above Critical Moving Average  Nasdaq

APGE Makes Bullish Cross Above Critical Moving Average - Nasdaq

Click here to get full coverage on Positive Phase 2 Data from APGE Bolsters Spyre Therapeutics’ Strategy and Stock Appeal - TipRanks

Positive Phase 2 Data from APGE Bolsters Spyre Therapeutics’ Strategy and Stock Appeal  TipRanks

Positive Phase 2 Data from APGE Bolsters Spyre Therapeutics’ Strategy and Stock Appeal - TipRanks

Click here to get full coverage on Citigroup Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq

Citigroup Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation  Nasdaq

Citigroup Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq

Click here to get full coverage on Here’s Why Apogee Therapeutics, Inc. (APGE) Will Double in 2025 - Yahoo Finance

Here’s Why Apogee Therapeutics, Inc. (APGE) Will Double in 2025  Yahoo Finance

Here’s Why Apogee Therapeutics, Inc. (APGE) Will Double in 2025 - Yahoo Finance

Click here to get full coverage on BofA Securities Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $78 - 富途牛牛

BofA Securities Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $78  富途牛牛

BofA Securities Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $78 - 富途牛牛

Click here to get full coverage on Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket  Benzinga

Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Stifel Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $95 - 富途牛牛

Stifel Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $95  富途牛牛

Stifel Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $95 - 富途牛牛

Click here to get full coverage on Insider Purchases Worth US$990.8k See Losses As Apogee Therapeutics Market Value Drops To US$1.9b - simplywall.st

Insider Purchases Worth US$990.8k See Losses As Apogee Therapeutics Market Value Drops To US$1.9b  simplywall.st

Insider Purchases Worth US$990.8k See Losses As Apogee Therapeutics Market Value Drops To US$1.9b - simplywall.st

Click here to get full coverage on Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results - Stock Titan

Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results  Stock Titan

Apogee Therapeutics Provides Business Update, Pipeline Progress and Reports First Quarter 2025 Financial Results - Stock Titan

Click here to get full coverage on Noteworthy Wednesday Option Activity: JOBY, APGE, M - Nasdaq

Noteworthy Wednesday Option Activity: JOBY, APGE, M  Nasdaq

Noteworthy Wednesday Option Activity: JOBY, APGE, M - Nasdaq

Click here to get full coverage on Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga

Dow Dips 1%; Mustang Bio Shares Spike Higher  Benzinga

Dow Dips 1%; Mustang Bio Shares Spike Higher - Benzinga

Click here to get full coverage on Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN

Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma  MSN

Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN

Click here to get full coverage on Apogee Therapeutics Reports Positive Phase 2 Trial Results - TipRanks

Apogee Therapeutics Reports Positive Phase 2 Trial Results  TipRanks

Apogee Therapeutics Reports Positive Phase 2 Trial Results - TipRanks

Click here to get full coverage on Apogee Therapeutics: No Clinical Efficacy Data, Strong Competition, High Market Cap - Seeking Alpha

Apogee Therapeutics: No Clinical Efficacy Data, Strong Competition, High Market Cap  Seeking Alpha

Apogee Therapeutics: No Clinical Efficacy Data, Strong Competition, High Market Cap - Seeking Alpha

Click here to get full coverage on Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL) - Benzinga

Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL)  Benzinga

Gold Falls 1%; ProKidney Shares Spike Higher - Apogee Therapeutics (NASDAQ:APGE), Blue Gold (NASDAQ:BGL) - Benzinga

Click here to get full coverage on Insider Purchase: Director at $APGE (APGE) Buys 12,500 Shares - Nasdaq

Insider Purchase: Director at $APGE (APGE) Buys 12,500 Shares  Nasdaq

Insider Purchase: Director at $APGE (APGE) Buys 12,500 Shares - Nasdaq

Click here to get full coverage on Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

Apogee Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis - Seeking Alpha

Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis  Seeking Alpha

Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis - Seeking Alpha

Click here to get full coverage on APGE Stock Analysis and Forecast - Free Consultation - AutoCar Pro

APGE Stock Analysis and Forecast - Free Consultation  AutoCar Pro

APGE Stock Analysis and Forecast - Free Consultation - AutoCar Pro

Click here to get full coverage on What’s next for APGE stock - Quarterly Earnings Report & Safe Entry Momentum Tips - 뉴스임팩트

What’s next for APGE stock - Quarterly Earnings Report & Safe Entry Momentum Tips  뉴스임팩트

What’s next for APGE stock - Quarterly Earnings Report & Safe Entry Momentum Tips - 뉴스임팩트

Click here to get full coverage on Can APGE stock recover from recent decline - Free Buy/Sell Signal Notifications - Jammu Links News

Can APGE stock recover from recent decline - Free Buy/Sell Signal Notifications  Jammu Links News

Can APGE stock recover from recent decline - Free Buy/Sell Signal Notifications - Jammu Links News

Click here to get full coverage on Apogee Therapeutics' Innovative Leap In Atopic Dermatitis Management (NASDAQ:APGE) - Seeking Alpha

Apogee Therapeutics' Innovative Leap In Atopic Dermatitis Management (NASDAQ:APGE)  Seeking Alpha

Apogee Therapeutics' Innovative Leap In Atopic Dermatitis Management (NASDAQ:APGE) - Seeking Alpha

Click here to get full coverage on Lubbockites have more than 30 options for new power providers: Here's the list - Lubbock Avalanche-Journal

Lubbockites have more than 30 options for new power providers: Here's the list  Lubbock Avalanche-Journal

Lubbockites have more than 30 options for new power providers: Here's the list - Lubbock Avalanche-Journal

Click here to get full coverage on Check out Apogee Therapeutics's stock price (APGE) in real time - CNBC

Check out Apogee Therapeutics's stock price (APGE) in real time  CNBC

Check out Apogee Therapeutics's stock price (APGE) in real time - CNBC

Click here to get full coverage on APGE - Apogee Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

APGE - Apogee Therapeutics Inc Latest Stock News & Market Updates  Stock Titan

APGE - Apogee Therapeutics Inc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics - PR Newswire

Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics  PR Newswire

Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics - PR Newswire

Click here to get full coverage on Heatmap analysis for APGE and competitors - Trade Signal Summary & Free Community Supported Trade Ideas - newser.com

Heatmap analysis for APGE and competitors - Trade Signal Summary & Free Community Supported Trade Ideas  newser.com

Heatmap analysis for APGE and competitors - Trade Signal Summary & Free Community Supported Trade Ideas - newser.com

Click here to get full coverage on CV curves of PtCu/APGEs synthesized during different times of galvanic... - researchgate.net

CV curves of PtCu/APGEs synthesized during different times of galvanic...  researchgate.net

CV curves of PtCu/APGEs synthesized during different times of galvanic... - researchgate.net

Click here to get full coverage on Analyzing APGE with multi timeframe charts - Analyst Downgrade & Expert Curated Trade Setups - newser.com

Analyzing APGE with multi timeframe charts - Analyst Downgrade & Expert Curated Trade Setups  newser.com

Analyzing APGE with multi timeframe charts - Analyst Downgrade & Expert Curated Trade Setups - newser.com

Click here to get full coverage on Analyzing APGE with multi timeframe charts - Weekly Market Outlook & Accurate Technical Buy Alerts - newser.com

Analyzing APGE with multi timeframe charts - Weekly Market Outlook & Accurate Technical Buy Alerts  newser.com

Analyzing APGE with multi timeframe charts - Weekly Market Outlook & Accurate Technical Buy Alerts - newser.com

Click here to get full coverage on How to build a dashboard for APGE stock - Insider Selling & Reliable Breakout Stock Forecasts - newser.com

How to build a dashboard for APGE stock - Insider Selling & Reliable Breakout Stock Forecasts  newser.com

How to build a dashboard for APGE stock - Insider Selling & Reliable Breakout Stock Forecasts - newser.com

Click here to get full coverage on Risk adjusted return profile for APGE analyzed - Stop Loss & Expert Verified Movement Alerts - newser.com

Risk adjusted return profile for APGE analyzed - Stop Loss & Expert Verified Movement Alerts  newser.com

Risk adjusted return profile for APGE analyzed - Stop Loss & Expert Verified Movement Alerts - newser.com

Click here to get full coverage on What to expect from APGE in the next 30 days - Take Profit & Weekly High Potential Alerts - newser.com

What to expect from APGE in the next 30 days - Take Profit & Weekly High Potential Alerts  newser.com

What to expect from APGE in the next 30 days - Take Profit & Weekly High Potential Alerts - newser.com

Click here to get full coverage on Real time social sentiment graph for APGE - Stop Loss & Fast Momentum Entry Tips - newser.com

Real time social sentiment graph for APGE - Stop Loss & Fast Momentum Entry Tips  newser.com

Real time social sentiment graph for APGE - Stop Loss & Fast Momentum Entry Tips - newser.com

Click here to get full coverage on Custom strategy builders for tracking APGE - Portfolio Gains Summary & Daily Growth Stock Investment Tips - newser.com

Custom strategy builders for tracking APGE - Portfolio Gains Summary & Daily Growth Stock Investment Tips  newser.com

Apogee Therapeutics, Inc. Common Stock (APGE)

Price Chart

Key Statistics

Technicals

About APGE

Latest News

BofA Raises Apogee Therapeutics (APGE) PT to $87 Following Positive Phase 2 APEX Trial Results for Atopic Dermatitis - Yahoo Finance

Apogee Therapeutics Inc. $APGE Shares Sold by Siren L.L.C. - MarketBeat

Apogee Therapeutics (APGE) To Showcase APG777 At EADV Congress 2025 - simplywall.st

Advanced Charts

Top Gainers

Top Losers